Mangoceuticals (MGRX) Non-Current Assets (2022 - 2026)

Mangoceuticals (MGRX) has 5 years of Non-Current Assets data on file, last reported at $14.2 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 34.02% year-over-year to $14.2 million; the trailing twelve-month figure through Mar 2026 stood at $14.2 million (down 34.02% YoY), and the FY2025 full-year result was $14.5 million, down 4.92% from the prior year.
• Non-Current Assets eased to $14.2 million in Q1 2026, from $14.5 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $21.6 million in Q1 2025 to a low of $211639.0 in Q1 2024.
• A 5-year average of $9.5 million and a median of $14.4 million in 2025 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets surged 10095.29% in 2025 and sank 34.02% in 2026, its largest moves.
• Tracing MGRX's Non-Current Assets over 5 years: stood at $308682.0 in 2022, then tumbled by 30.22% to $215391.0 in 2023, then soared by 7001.0% to $15.3 million in 2024, then decreased by 4.92% to $14.5 million in 2025, then declined by 2.1% to $14.2 million in 2026.
• Business Quant data shows MGRX's Non-Current Assets at $14.2 million in Q1 2026, $14.5 million in Q4 2025, and $15.9 million in Q3 2025.